October 16, 2020 – Dan Hargrave was struggling to breathe, and he and his physicians initially were not sure why. He had asthma as a child, but his doctors were not confident this was the cause. Eventually, Dan was diagnosed with chronic obstructive … [Read More...]
Drug Industry Report on 340B Attempts a Diversion from Unlawful Manufacturer Actions
Print ArticleOctober 14, 2020— A new report from the drug industry consultant Berkeley Research Group (BRG) takes aim at community-based pharmacies in the 340B drug pricing program. The report implies, without evidence, that for-profit pharmacy chains are making excessive profits on these arrangements. It ignores the fact that these partnerships provide critical funding for safety-net […]
340B Hospitals Support Mental Health Challenges No Matter the Circumstances
Print ArticleOctober 9, 2020 – Fifty percent. According to the Centers for Disease Control and Prevention (CDC), this is the estimated percentage of Americans who will be diagnosed with a mental illness or disorder in their lifetime. Prior to the COVID-19 pandemic, mental health already was one of the top health challenges Americans faced. But as we […]
FOLLOW | SHARE | LIKE
